Structural requirements for the cytotoxicity of the N-terminal region of HIV type 1 Nef

AIDS Research and Human Retroviruses

Volumn 14, Issue 17, 1998, Pages 1543-1551

  Curtain, Cyril C ^a   Lowe, Melinda G ^a   Macreadie, Ian G ^a   Gentle, Ian R ^b   Lawrie, Gwendolyn A ^b   Azad, Ahmed A ^a  

^a CSIRO   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CYTOTOXICITY; HEMOLYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 0032553481     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.1543     Document Type: Article

References (40)

1. Curtain CC, Lowe MG, Arunagiri CK, Mobley PW, Macreadie IG, and Azad AA: Cytotoxic activity of the amino-terminal region of HIV type 1 Nef protein. AIDS Res Hum Retroviruses 1997;13: 1213-1220.
2. Curtain CC, Separovic F, Rivett D, Kirkpatrick A, Waring AJ, Gordon LM, and Azad AA: Fusogenic activity of amino-terminal region of HIV type 1 Nef protein. AIDS Res Hum Restroviruses 1994;10:1231-1240.
3. Barnham KJ, Monks SA, Hinds MG, Azad AA, and Norton RS: Solution structure of a polypeptide from the N-terminus of the HIV protein Nef. Biochemistry 1997;36:5970-5980.
4. 1H NMR study in methanol. Eur J Biochem 1988;173:139-146.
5. Terwilliger TC and Eisenberg D: The structure of melittin. II. Interpretation of the structure. J Biol Chem 1982;268:6016-6022.
6. Terwilliger TC and Eisenberg D: The structure of melittin in form 1 crystals and its implication for melittin's lytic and surface activities. Biophys J 1982;37:5970-5980.
7. Teikichi I, Nobuhiro G, and Fuyihiko I: Refined structure of melittin bound to perdeuterated dodecylphosphocholine micelles as studied by 2D-NMR and distance geometry calculation. Proteins Struct Func Genet 1991;9:81-89.
8. Okada A, Wakamatsu K, Miyazawa T, and Higashijima T: Vesicle-bound conformation of melittin: Transferred nuclear Overhauser enhancement analysis in the presence of perdeuterated phosphatidylcoline vesicles. Biochemistry 1994;33:9438-9446.
9. Garcia JV and Miller AD: Serine phosphorylation independent downregulation of cell-surface CD4 by nef. Nature (London) 1991;350:508-511.
10. Goldsmith MA, Warmerdam MT, Atchison RE, Miller MD, and Greene WC: Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J Virol 1995;69:4112-4121.
11. Benson RE, Sanfridson A, Ottinger JS, Doyle C, and Cullen BR: Downregulation of cell-surface CD4 expression by SIV Nef prevents viral superinfection. J Exp Med 1993;177:1561-1566.
12. Greenway A, Grgacic E, Hewish D, McPhee D, Macreadie I, and Azad AA: Biological activity of Nef: Nef downregulates expression of CD4 and the IL2 receptor. Virology 1993;198:245-256.
13. Luria S, Chambers I, and Berg P: Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin-2 mRNA. Proc Natl Acad Sci USA 1991;88:5326-5330.
14. Guy B, Riviere Y, Dott K, Regnault A, and Kieny MP: Mutational analysis of the HIV Nef.protein. Virology 1990;176:413-425.
15. Lee C-H, Leung B, Lemmon MA, Jie Z, Cowburn D, Kuriyan J, and Saksela K: A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J 1995;14:5006-5015.
16. Luciw PA, Cheng-Mayer C, and Levy JA: Mutational analysis of the human immunodeficiency virus: The orf-B region down-regulates virus replication. Proc Natl Acad Sci USA 1987;84: 1434-1438.
17. Saksela K, Cheng G, and Baltimore D: Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef viruses but not for down-regulation of CD4. EMBO J 1995;14:484-491.
18. Sawai ET, Baur A, Struble H, Peterlin BM, Levy JA, and Cheng-Mayer C: Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc Natl Acad Sci USA 1994;91:1539-1543.
19. Sawai ET, Baur A, Struble H, Peterlin BM, Levy JA, and Cheng-Mayer C: A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J Biol Chem 1995;270:15307-15314.
20. lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proc Natl Acad Sci USA 1995;92:349-353.
21. Baur SA, Sass G, Laffert B, Willbold D, Cheng-Mayer C, and Peterlin M: The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 1997;6:283-291.
22. Macreadie IG, Castelli LA, Lucantoni A, and Azad AA: Stress-and sequence-dependent release into the culture medium of HIV-1 Nef produced in Saccharomyces cerevisiae. Gene 1995;162: 239-243.
23. Macreadie IG, Lowe MG, Curtain CC, Hewish DR, and Azad AA: Cytotoxicity resulting from addition of HIV-1 Nef N-terminal peptides to yeast and bacterial cells. Biochem Biophys Res Commun 1997;232:707-711.
24. + T lymphocytes and for the blocking of the Nef fuction by anti-Nef antibodies. Vaccine 1993;11:837-847.
25. Saksena NK, Ying ChG, Bin W, Shi-Hua X, Ziegler J, Palasanthiran P, Bolton W, and Cunningham AL: RNA and DNA sequence analysis of the nef gene of HIV type 1 strains from first HIV type 1-infected long-term nonprogressing mother-child pair. AIDS Res Hum Retroviruses 1997;13:729-732.
26. Andrade MA, Chacon P, Merelo JJ, and Moran F: Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network. Protein Eng 1993;6:383-390.
27. Merelo JJ, Andrade MA, Prieto A, and Moran F: Proteinotopic feature maps. Neurocomputing 1994;6:1-12.
28. Stultz CM, White JV, and Smith TF: Structural analysis based on state-space modelling Protein Sci 1993;2:305-314.
29. White JV, Stultz CM, and Smith TF: Protein classification by stochastic modelling and optimal filtering of amino-acid sequences. Math Biosci 1994;119:35-75.
30. Hoekstra D, de Boer T, Klapp K, and Wilschut J: Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 1984;23:5675-5684.
31. Werkmeister JA, Kirkpatrick A, McKenzie JA, and Rivett DE: The effect of sequence variations and structure on the cytolytic activity of melittin peptides. Biochim Biophys Acta 1993;1157:50-54.
32. Macreadie IG, Sankovich SA, Failla P, Lowe M, Curtain CC, Castelli LA, and Azad AA: HIV-1 Nef protein causes death in stressed yeast cells due to determinants near the N-terminus and elsewhere in Nef. Biochem Mol Biol Int 1998 (in press).
33. Macreadie IG, Femley R, Castelli LA, Lucantoni A, White J, and Azad AA: Expression of HIV-1 nef in yeast causes membrane perturbation and release of the myristylated Nef protein. J Biomed Sci 1998;195:203-310.
34. Bukovsky AA, Dorfman T, Weimann A, and Gottlinger HG: nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J Virol 1997;71:1013-1018.
35. Pandori MW, Fitch NJS, Craig HM, Richman DD, Spina CA, and Guatelli JC: Producer-cell modification of human immunodeficiency virus type 1: nef is a virion protein. J Virol 1996;70: 4283-4290.
36. Welker R, Kottler H, Kalbitzer HR, and Krausslich H-G: Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 1996;219:228-236.
37. Greenway A, Azad A, Mills J, and McPhee D: Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J Virol 1996;70: 6701-6708.
38. src. J Cell Biol 1992;119:515-425.
39. McLaughlin S and Aderem A: The myristoyl-electrostatic switch: A modulator of reversible protein-membrane interactions. Trends Biochem Sci 1995;20:272-276.
40. src at the membrane interface. Biochemistry 1998;37:3402-3410.